Surveillance bronchoscopy in children during the first year after lung transplantation: Is it worth it?

C Benden1, O Harpur-Sinclair, A S Ranasinghe

  • 1Cardio-Respiratory and Critical Care Division, Great Ormond Street Hospital for Children National Health Service Trust, London, UK.

Thorax
|August 25, 2006
PubMed

Insights

Routine surveillance bronchoscopy in pediatric lung transplant recipients reveals significant rates of silent rejection and subclinical infections. Early detection through bronchoscopy aids in timely treatment of these critical post-transplant complications.

Area of Science:

  • Pediatric Transplantation
  • Pulmonary Medicine
  • Immunology

Background:

  • Established routine surveillance bronchoscopy with bronchoalveolar lavage (BAL) and transbronchial biopsy for pediatric lung and heart-lung transplant recipients since 2002.
  • Utilized a revised treatment protocol for post-transplant care in pediatric patients.

Purpose of the Study:

  • To determine the prevalence of rejection and pathogens (bacterial, viral, fungal) in asymptomatic pediatric lung transplant recipients.
  • To compare these findings with the prevalence in symptomatic pediatric lung transplant recipients.

Main Methods:

  • Retrospective analysis of pediatric patients undergoing lung or heart-lung transplantation between January 2002 and December 2005.
  • Scheduled surveillance bronchoscopies at 1 week, 1, 3, 6, and 12 months post-transplant.
  • Classification of bronchoscopies based on the presence or absence of specific symptoms indicative of complications.

Main Results:

  • Rejection was diagnosed in 4% of asymptomatic and 12% of symptomatic recipients.
  • Pathogens were detected in 29% of asymptomatic and 69% of symptomatic patients.
  • Bronchoscopy yielded diagnoses in 35% of asymptomatic and 85% of symptomatic children (p < 0.001), with a 3.2% complication rate.

Conclusions:

  • A significant proportion of pediatric lung transplant recipients experience subclinical rejection or infection within the first year.
  • Routine surveillance bronchoscopy is effective in detecting these silent complications.
  • Early detection facilitates targeted treatment, improving outcomes in pediatric lung transplant patients.
Abstract